Tirzepatide 5mg

Tirzepatide 5mg

What Is Tirzepatide 

Tirzepatide is a novel dual agonist peptide that targets both the GLP-1 and GIP receptors. It is currently being studied for its powerful effects on glucose regulation, insulin sensitivity, and body weight management. This compound is gaining traction in metabolic research due to its ability to influence multiple hormonal pathways involved in appetite, glucose control, and energy usage.

Tirzepatide Known Benefits Based on Research

• May support scientific studies on blood sugar control and insulin regulation
• Known for its potential in weight loss and obesity research
• Could assist in appetite regulation and caloric intake studies
• May benefit investigations on lipid metabolism and cardiovascular health
• Useful for studying the combined effects of GIP and GLP-1 receptor agonism

Tirzepatide Molecular Formula

C225H348N48O68

Product Features

• Contains 5mg of Tirzepatide in lyophilized powder form
• Research-grade purity for advanced metabolic and endocrine studies
• Precisely measured and packaged for consistent dosing
• Ideal for research on glucose control, weight loss mechanisms, and metabolic regulation
• Securely sealed for safe storage and handling

 Tirzepatide (Dual GIP/GLP‑1 Agonist)

• Phase III RCT (72 weeks, obesity): NEJM
• SURPASS Trials (diabetes & weight loss context): Diabetes Obesity Metab. 

Safety Disclaimer

This product is intended for research purposes only. It is not intended for human consumption or medical use.